EX-23.2 4 tv508725_ex23-2.htm EXHIBIT 23.2

 

Exhibit 23.2

  

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-3 of Sorrento Therapeutics, Inc. and Subsidiaries, of our report dated March 14, 2016, with respect to the consolidated financial statements for the year ended December 31, 2015, which appears in the Annual Report on Form 10-K for the year ended December 31, 2017, and to the reference to us under the heading “Experts” in this Prospectus which is part of this Registration Statement.

 

/s/ Mayer Hoffman McCann P.C.  
San Diego, California  
December 12, 2018